WCMNY
TVGN icon

Westchester Capital Management (New York)’s Tevogen Inc. Common Stock TVGN Stock Holding History

Westchester Capital Management (New York)’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,999
Closed -$1.11M – 261
2023
Q4 		$1.11M Hold
1,999
– – 0.04% 181
2023
Q3 		$1.08M Buy
+1,999
New +$1.08M 0.03% 213
2023
Q1 		– Sell
-22,630
Closed -$11.7M – 386
2022
Q4 		$11.7M Buy
22,630
+18,523
+451% +$9.48M 0.32% 64
2022
Q3 		$2.09M Buy
+4,107
New +$2.07M 0.06% 268

Other funds holding TVGN

PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Westchester Capital Management (New York)'s TVGN Position: Q1 2024 in Review

Westchester Capital Management (New York) sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2024, closing a stake of 1,999 shares — an estimated $1.11M sold.

Westchester Capital Management (New York) first reported a position in TVGN in Q3 2022 and held it in 4 quarters. The position peaked at $11.7M in Q4 2022. 5 funds tracked by Wall St. Rank hold TVGN as of Q1 2024.

  • Westchester Capital Management (New York) reported no remaining Tevogen Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 1,999 Tevogen Inc. Common Stock shares in Q1 2024, an estimated $1.11M.
  • Westchester Capital Management (New York) first reported a position in Tevogen Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Westchester Capital Management (New York)'s Tevogen Inc. Common Stock position peaked at $11.7M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2024.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2024, filed 15 May 2024.